Holley Pharmaceutical

Holley Pharmaceutical is a leading Chinese pharmaceutical company and a core subsidiary of the Holley Group, headquartered in Hangzhou. The company is globally recognized for its pioneering role in the industrialization and commercialization of artemisinin-based anti-malarial therapies, significantly contributing to global health efforts. Beyond its leadership in infectious diseases, Holley Pharmaceutical develops and manufactures a diverse range of traditional Chinese medicines, chemical generics, and active pharmaceutical ingredients (APIs). It operates state-of-the-art GMP-certified facilities and maintains an extensive distribution network across Africa and Southeast Asia. The company continues to focus on expanding its portfolio in cardiovascular and metabolic health while sustaining its commitment to global malaria eradication.